Tirzepatide Impact Assessment Study

This longitudinal study aims to explore the impact of tirzepatide/semaglutide on psychological health, appetite-related hormones, and cardiometabolic factors in individuals undergoing treatment for weight loss. By assessing changes and relationships between these factors over time, we hope to gain a deeper understanding of how this medication influences not only weight, but also mental and physical health outcomes. Our findings will contribute to more comprehensive strategies for weight management and well-being.

Collaborators: Dr. Allison Childress, Dr. Shannon Galyean, Dr. Marleigh Hefner, and Dr. Andy Shin